Skip to content

Agenus

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    BeiGene and Agenus reach China rights agreement for two cancer antibodies

    BeiGene announced that it had reached an agreement with Agenus for exclusive rights in China, including Hong Kong, Macao and Taiwan, to develop and commercialize Balstilimab and Zalifrelimab for specified indications and uses.